Inventor · disambiguated record
Horacio Uri Saragovi
Also filed as: SARAGOVI HORACIO U · SARAGOVI HORACIO URI
10 granted patents·10 pending applications·98 citations·filing 1992–2023
86Inventor score
Top patents by PatentIndex Score
20 records- 0191US6881719B2β-turn peptidomimetic cyclic compoundsTEXAS A & M UNIV SYS·Filed 2001·Granted Apr 19, 2005·49 cites·16 claims
- 0278US5334702ACompositions which are immunologically crossreactive with antibodies and preparative methods thereforUNIV ILLINOIS·Filed 1992·Granted Aug 2, 1994·40 cites·1 claims
- 0377US10066229B2Treatment using truncated Trk B and Trk C antagonistsOTONOMY INC·Filed 2016·Granted Sep 4, 2018·1 cites·23 claims
- 0471US8653036B2Methods of treating retinitis pigmentosaCUMBERLIDGE GARTH·Filed 2010·Granted Feb 18, 2014·3 cites·8 claims
- 0570US9200080B2Agonistic antibodies to TrkC receptors and uses thereofSARAGOVI HORACIO URI·Filed 2010·Granted Dec 1, 2015·2 cites·20 claims
- 0666US9296691B2Inhibitors of p75 receptor and their usesSARAGOVI HORACIO URI·Filed 2011·Granted Mar 29, 2016·2 cites·5 claims
- 0766US2024042000A1Carbohydrate structures and uses thereofAOA DX·Filed 2023·Application pending·0 cites
- 0865US11034961B2Treatment using truncated Trk B and Trk C antagonistsOTONOMY INC·Filed 2018·Granted Jun 15, 2021·0 cites·21 claims
- 0965US2020190201A1Trkb or trkc agonist compositions and methods for the treatment of otic conditionsOTONOMY INC·Filed 2019·Application pending·0 cites
- 1063US10363305B2Anti-ganglioside compound for targeting cancer and generating antibodiesREALIST PHARMA INC·Filed 2014·Granted Jul 30, 2019·1 cites·11 claims
- 1161US2023416399A1Methods for treating cancer with anti-gd2/gd3 antibodiesSARAGOVI HORACIO URI·Filed 2023·Application pending·0 cites
- 1255US11786586B2Carbohydrate structures and uses thereofAOA DX·Filed 2017·Granted Oct 17, 2023·0 cites·18 claims
- 1355US2025224402A1Mass spectrometry methods for cancer diagnosisAOA DX·Filed 2023·Application pending·0 cites
- 1451US9707267B2Beta-turn peptidomimetic cyclic compounds for treating dry eyeMIMETOGEN PHARMACEUTICALS INC·Filed 2015·Granted Jul 18, 2017·0 cites·14 claims
- 1548US2025277793A1Compositions and methods for cancer diagnosisAOA DX·Filed 2021·Application pending·0 cites
- 1646US2019374606A1Neurotrophin mutants for treating hearing loss and other otic disordersOTONOMY INC·Filed 2018·Application pending·0 cites
- 1746US2016130363A1Agonistic antibodies to trkc receptors and uses thereofUNIV BRITISH COLUMBIA·Filed 2015·Application pending·0 cites
- 1845US2017029511A1Trkb or trkc agonist compositions and methods for the treatment of otic conditionsOTONOMY INC·Filed 2016·Application pending·0 cites
- 1939US2021179684A1Neurotrophin mutants and use thereof for treating neurodegenerative diseases and disordersSARAGOVI HORACIO URI·Filed 2018·Application pending·0 cites
- 2037US2017029823A1Truncated trk b and trk c antagonists and uses thereofSARAGOVI HORACIO URI·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →